Clinical Trials at Alabama Oncology, Shelby
As of July 2026, 1 paid clinical trial is recruiting at Alabama Oncology, Shelby in Alabaster, Alabama. Active studies at this site cover conditions such as APOL1-Mediated Kidney Disease, Focal Segmental Glomerulosclerosis and Non-Small Cell Lung Cancer Metastatic. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
1 clinical trial at Alabama Oncology, Shelby
·Clear filters·Common conditions studied in Alabaster
- APOL1-Mediated Kidney Disease (1 active study)
- Focal Segmental Glomerulosclerosis (1 active study)
- Non-Small Cell Lung Cancer Metastatic (1 active study)
- Non-Small Cell Lung Carcinoma (1 active study)
- Non-small Cell Carcinoma (1 active study)
- Primary IgA Nephropathy (1 active study)
Leading research sponsors in Alabaster
- AstraZeneca
- Boehringer Ingelheim
- Hoffmann-La Roche
- Pfizer
- Vertex Pharmaceuticals Incorporated
Frequently asked questions
How many paid clinical trials are currently recruiting in Alabaster?
There are approximately 5 recruiting clinical trials in Alabaster, Alabama listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Alabaster pay participants?
Most recruiting trials in Alabaster compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Alabaster?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Alabaster?
The most common conditions under active study in Alabaster include APOL1-Mediated Kidney Disease (1), Focal Segmental Glomerulosclerosis (1), Non-Small Cell Lung Cancer Metastatic (1), Non-Small Cell Lung Carcinoma (1), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Alabaster?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Alabaster on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Alabaster?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Alabaster?
Recruiting research sites in Alabaster include Alabama Kidney Research, Alabama Kidney Research - ERN - PPDS, Alabama Oncology, Shelby, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Alabaster right now?
The largest active categories in Alabaster are Cancer & tumors (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.